Evolution of the Average Target: Sartorius AG

Evolution of the Target Price: Sartorius AG

Changes in Analyst Recommendations: Sartorius AG

0c1283d7d6b94b.zQNzVD5fZpIthLxL_oAQY_OU_lrx6oKquvOwAKyr1NE.iWJCHnoLJdVMtNkxqd9zF5DgtRiykObe1YPmaebn-aG3XDgufx0l3G737Q~fcbc5cf2bc8187f17d91548fea7e7f98
07-30 SARTORIUS VORZUEGE : Bernstein reiterates its Buy rating ZD
07-28 SARTORIUS VORZUEGE : Deutsche Bank reiterates its Buy rating ZD
07-27 SARTORIUS VORZUEGE : DZ Bank reiterates its Neutral rating ZD
07-24 Sartorius: Mixed Q2 26: Tariff accounting distorts the results Alphavalue
07-24 SARTORIUS VORZUEGE : Receives a Buy rating from Deutsche Bank ZD
07-24 SARTORIUS VORZUEGE : Buy rating from Berenberg ZD
07-24 SARTORIUS VORZUEGE : Buy rating from JP Morgan ZD
07-23 Sartorius briefly turns positive, support level in focus DP
07-23 SARTORIUS VORZUEGE : Receives a Buy rating from Bernstein ZD
07-23 Bernstein keeps Sartorius at 'Outperform', target €284 DP
07-23 SARTORIUS VORZUEGE : RBC remains Neutral ZD
07-21 SARTORIUS VORZUEGE : Gets a Buy rating from Bernstein ZD
07-16 MedTech facing a three-front squeeze Alphavalue
07-13 SARTORIUS VORZUEGE : UBS gives a Neutral rating ZD
07-10 Berenberg Ups Sartorius AG Price Target Ahead of Q2 Results; Buy Rating Kept MT
07-10 SARTORIUS VORZUEGE : Berenberg reiterates its Buy rating ZD
06-23 SARTORIUS VORZUEGE : Goldman Sachs sticks Neutral ZD
06-23 Goldman Cuts Sartorius Target to €229, Keeps 'Neutral' DP
06-23 SARTORIUS VORZUEGE : DZ Bank reaffirms its Neutral rating ZD
06-22 SARTORIUS VORZUEGE : JP Morgan gives a Buy rating ZD
06-22 SARTORIUS VORZUEGE : Receives a Buy rating from Deutsche Bank ZD
06-08 Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk MT
06-05 Sartorius AG out of favor, as mwb research maintains Sell rating Zonebourse
06-05 Sartorius AG Out of Favor as mwb research Maintains Sell Rating Zonebourse
05-26 Sartorius AG Price Target, Estimates Down at AlphaValue/Baader Europe Post-FY26 Guidance MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +54.25%
+27.21%
+58.71%
+109.3%
+60.86%
+47.3%
+19.34%
+37.33%
Average +51.79%
Weighted average by Cap. +51.82%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
218.00EUR
Average target price
265.95EUR
Spread / Average Target
+21.99%
High Price Target
307.00EUR
Spread / Highest target
+40.83%
Low Price Target
190.00EUR
Spread / Lowest Target
-12.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BERNSTEIN RESEARCH Delphine Le Louet
DZ BANK Sven Kürten
alphavalue Jitisha Malhotra
RBC Charles Weston
JPMORGAN Richard Vosser
BERENBERG Harry Gillis
UBS Matthew Weston
GOLDMAN SACHS James Quigley
JEFFERIES James Vane-Tempest
BARCLAYS Charles Pitman-King
DEUTSCHE BANK RESEARCH Falko Friedrichs
Morningstar
WARBURG RESEARCH Michael Heider
AlphaValue/Baader Europe
ODDO BHF Oliver Metzger
CREDIT SUISSE Dominic Lunn
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
218.00EUR
Average target price
265.95EUR
Spread / Average Target
+21.99%

Quarterly revenue - Rate of surprise